

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.95557729 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.76723075 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.72508369 |
| 4 | vocalization behavior (GO:0071625) | 5.61231401 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.50129575 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.30514020 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.27585973 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.16998244 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.10962937 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.98818053 |
| 11 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.81848907 |
| 12 | protein localization to synapse (GO:0035418) | 4.77854189 |
| 13 | glutamate secretion (GO:0014047) | 4.73412239 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.67052491 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.62625222 |
| 16 | exploration behavior (GO:0035640) | 4.58966652 |
| 17 | glutamate receptor signaling pathway (GO:0007215) | 4.58319512 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.56294414 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.53158118 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 4.50710131 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 4.50246701 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.36637422 |
| 23 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.34969923 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.33712399 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.33332234 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 4.23633066 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.20384028 |
| 28 | presynaptic membrane organization (GO:0097090) | 4.18933311 |
| 29 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.18443992 |
| 30 | presynaptic membrane assembly (GO:0097105) | 4.17690047 |
| 31 | layer formation in cerebral cortex (GO:0021819) | 4.13605529 |
| 32 | long-term memory (GO:0007616) | 4.13390377 |
| 33 | dendritic spine morphogenesis (GO:0060997) | 4.09563442 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.07503503 |
| 35 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.03857551 |
| 36 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.01863969 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.95902110 |
| 38 | gamma-aminobutyric acid transport (GO:0015812) | 3.93597355 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.86839323 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.86470816 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.84438600 |
| 42 | cellular potassium ion homeostasis (GO:0030007) | 3.76879619 |
| 43 | regulation of synaptic plasticity (GO:0048167) | 3.75969140 |
| 44 | transmission of nerve impulse (GO:0019226) | 3.74969330 |
| 45 | startle response (GO:0001964) | 3.74052932 |
| 46 | neuron recognition (GO:0008038) | 3.71579444 |
| 47 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.69441374 |
| 48 | prepulse inhibition (GO:0060134) | 3.68868926 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.67858853 |
| 50 | response to histamine (GO:0034776) | 3.60757414 |
| 51 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.60408575 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.59730795 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.57545500 |
| 54 | short-term memory (GO:0007614) | 3.57370222 |
| 55 | neuromuscular process controlling balance (GO:0050885) | 3.54217304 |
| 56 | behavioral fear response (GO:0001662) | 3.52974688 |
| 57 | behavioral defense response (GO:0002209) | 3.52974688 |
| 58 | neurotransmitter transport (GO:0006836) | 3.51502793 |
| 59 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.49063795 |
| 60 | behavioral response to nicotine (GO:0035095) | 3.47820218 |
| 61 | auditory behavior (GO:0031223) | 3.44985741 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.44363803 |
| 63 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.43789040 |
| 64 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.40431081 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.40037551 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.39871840 |
| 67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.39395054 |
| 68 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.38885838 |
| 69 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.36163935 |
| 70 | axonal fasciculation (GO:0007413) | 3.34506897 |
| 71 | C4-dicarboxylate transport (GO:0015740) | 3.33924115 |
| 72 | regulation of dendritic spine development (GO:0060998) | 3.33622811 |
| 73 | sodium ion export (GO:0071436) | 3.32614101 |
| 74 | adult walking behavior (GO:0007628) | 3.32459791 |
| 75 | regulation of neurotransmitter levels (GO:0001505) | 3.31606435 |
| 76 | activation of protein kinase A activity (GO:0034199) | 3.31488891 |
| 77 | synaptic transmission, dopaminergic (GO:0001963) | 3.31397744 |
| 78 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.31042896 |
| 79 | fear response (GO:0042596) | 3.30235224 |
| 80 | striatum development (GO:0021756) | 3.29678374 |
| 81 | proline transport (GO:0015824) | 3.28975555 |
| 82 | learning (GO:0007612) | 3.27213588 |
| 83 | synaptic vesicle endocytosis (GO:0048488) | 3.26758988 |
| 84 | regulation of female receptivity (GO:0045924) | 3.25093822 |
| 85 | regulation of neurotransmitter secretion (GO:0046928) | 3.24653314 |
| 86 | dendritic spine organization (GO:0097061) | 3.24368888 |
| 87 | neuromuscular synaptic transmission (GO:0007274) | 3.24005397 |
| 88 | membrane depolarization (GO:0051899) | 3.23753173 |
| 89 | neuronal ion channel clustering (GO:0045161) | 3.23401562 |
| 90 | serotonin metabolic process (GO:0042428) | 3.22969443 |
| 91 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.21810693 |
| 92 | response to auditory stimulus (GO:0010996) | 3.21572264 |
| 93 | cell migration in hindbrain (GO:0021535) | 3.21509036 |
| 94 | righting reflex (GO:0060013) | 3.20686235 |
| 95 | positive regulation of action potential (GO:0045760) | 3.19419354 |
| 96 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.18749133 |
| 97 | positive regulation of dendritic spine development (GO:0060999) | 3.17906381 |
| 98 | regulation of glutamate secretion (GO:0014048) | 3.17806497 |
| 99 | cellular sodium ion homeostasis (GO:0006883) | 3.16009146 |
| 100 | membrane hyperpolarization (GO:0060081) | 3.15618158 |
| 101 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15032637 |
| 102 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.14219535 |
| 103 | cell differentiation in hindbrain (GO:0021533) | 3.12385089 |
| 104 | neuromuscular process controlling posture (GO:0050884) | 3.10722709 |
| 105 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.09720888 |
| 106 | response to amphetamine (GO:0001975) | 3.08499890 |
| 107 | vesicle transport along microtubule (GO:0047496) | 3.08452046 |
| 108 | regulation of neurotransmitter transport (GO:0051588) | 3.08298490 |
| 109 | urinary tract smooth muscle contraction (GO:0014848) | 3.07599744 |
| 110 | mating behavior (GO:0007617) | 3.07086269 |
| 111 | dendrite morphogenesis (GO:0048813) | 3.07053422 |
| 112 | positive regulation of synaptic transmission (GO:0050806) | 3.06694146 |
| 113 | establishment of mitochondrion localization (GO:0051654) | 3.06686806 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.06453435 |
| 115 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.05015231 |
| 116 | cerebellar Purkinje cell layer development (GO:0021680) | 3.04628922 |
| 117 | postsynaptic membrane organization (GO:0001941) | 3.03658727 |
| 118 | glycine transport (GO:0015816) | 3.03140535 |
| 119 | synapse assembly (GO:0007416) | 3.02801634 |
| 120 | membrane depolarization during action potential (GO:0086010) | 3.02111236 |
| 121 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.01002413 |
| 122 | negative regulation of dendrite development (GO:2000171) | 3.00813612 |
| 123 | regulation of synaptic transmission (GO:0050804) | 3.00592012 |
| 124 | synaptic transmission (GO:0007268) | 3.00149540 |
| 125 | long term synaptic depression (GO:0060292) | 2.99365784 |
| 126 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.98728475 |
| 127 | retinal cone cell development (GO:0046549) | 2.97579664 |
| 128 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.97495349 |
| 129 | neurofilament cytoskeleton organization (GO:0060052) | 2.97154004 |
| 130 | nucleobase catabolic process (GO:0046113) | 2.95408323 |
| 131 | primary amino compound metabolic process (GO:1901160) | 2.93826890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.13716632 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.55974486 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18673381 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16879632 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.14639229 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.86378910 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.75059550 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.75059550 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.73970037 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.71281073 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68400777 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55795120 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55470224 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.53956115 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52260556 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50803386 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49086121 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29885733 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25667151 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23930056 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21175306 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19877301 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19744452 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.06504160 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.04668469 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01695105 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97014641 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86919618 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78672320 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77052936 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.75729890 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75700652 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73281707 |
| 34 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.71878380 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.65124372 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63776005 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.57699838 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.54944677 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45574524 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43338886 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39530471 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38926713 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34527443 |
| 44 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32647113 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32220561 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31618825 |
| 47 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30160780 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30019304 |
| 49 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29606282 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28963783 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24808692 |
| 52 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24230169 |
| 53 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.23505396 |
| 54 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21553490 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.21383872 |
| 56 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19895239 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19274200 |
| 58 | AR_19668381_ChIP-Seq_PC3_Human | 1.18987144 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18945987 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17761812 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17655478 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17103127 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15870097 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15528605 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15205376 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13668166 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13490039 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13280959 |
| 69 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12170910 |
| 70 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11289439 |
| 71 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10803445 |
| 72 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10244675 |
| 73 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10002462 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08427999 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07581548 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.07434993 |
| 77 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06538956 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06424172 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06209950 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05938099 |
| 81 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05674445 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04557349 |
| 83 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04355584 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04051115 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03810560 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03293043 |
| 87 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03087984 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01730655 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01289518 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01242587 |
| 91 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00836608 |
| 92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00734005 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00495866 |
| 94 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.00100757 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99810552 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99417390 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99408934 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99246577 |
| 99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99233142 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99233142 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98475575 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97856159 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97706282 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97574786 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96018226 |
| 106 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95322049 |
| 107 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95049284 |
| 108 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95023738 |
| 109 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94904707 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93950299 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93487832 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92776379 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91915342 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90944831 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89412435 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88945128 |
| 117 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87590522 |
| 118 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87575668 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.86470691 |
| 120 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85930377 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85725471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.74302263 |
| 2 | MP0003880_abnormal_central_pattern | 5.13465985 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.34920128 |
| 4 | MP0002822_catalepsy | 4.07257031 |
| 5 | MP0009745_abnormal_behavioral_response | 3.67919187 |
| 6 | MP0004270_analgesia | 3.60701308 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.53989402 |
| 8 | MP0002064_seizures | 3.27030909 |
| 9 | MP0009046_muscle_twitch | 3.11526210 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.94874453 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.88010106 |
| 12 | MP0001486_abnormal_startle_reflex | 2.70799721 |
| 13 | MP0002272_abnormal_nervous_system | 2.70261214 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.62670503 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.51913592 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.43728566 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.23592319 |
| 18 | MP0002736_abnormal_nociception_after | 2.19497157 |
| 19 | MP0003329_amyloid_beta_deposits | 2.05155243 |
| 20 | MP0002735_abnormal_chemical_nociception | 1.99023865 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.91845763 |
| 22 | MP0002067_abnormal_sensory_capabilities | 1.91117168 |
| 23 | MP0008569_lethality_at_weaning | 1.90671651 |
| 24 | MP0001970_abnormal_pain_threshold | 1.88195474 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.85298622 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.80613975 |
| 27 | MP0004924_abnormal_behavior | 1.80613975 |
| 28 | MP0002184_abnormal_innervation | 1.76978552 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.76928372 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.76822602 |
| 31 | MP0001529_abnormal_vocalization | 1.73543687 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.69109187 |
| 33 | MP0000778_abnormal_nervous_system | 1.67517111 |
| 34 | MP0001984_abnormal_olfaction | 1.65230280 |
| 35 | MP0005646_abnormal_pituitary_gland | 1.59764149 |
| 36 | MP0003879_abnormal_hair_cell | 1.52863677 |
| 37 | MP0004885_abnormal_endolymph | 1.45200035 |
| 38 | MP0000955_abnormal_spinal_cord | 1.45100428 |
| 39 | MP0004858_abnormal_nervous_system | 1.45098886 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.41610022 |
| 41 | MP0001188_hyperpigmentation | 1.41572275 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.40752328 |
| 43 | MP0002882_abnormal_neuron_morphology | 1.36757741 |
| 44 | MP0003633_abnormal_nervous_system | 1.30760212 |
| 45 | MP0001905_abnormal_dopamine_level | 1.29011170 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.24265827 |
| 47 | MP0004142_abnormal_muscle_tone | 1.22150635 |
| 48 | MP0004147_increased_porphyrin_level | 1.15678955 |
| 49 | MP0003787_abnormal_imprinting | 1.15542436 |
| 50 | MP0003631_nervous_system_phenotype | 1.13479880 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.11504731 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.10773126 |
| 53 | MP0005409_darkened_coat_color | 1.10609211 |
| 54 | MP0008872_abnormal_physiological_respon | 1.08987720 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.08407739 |
| 56 | MP0002152_abnormal_brain_morphology | 1.05731675 |
| 57 | MP0008874_decreased_physiological_sensi | 1.03064930 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.02805907 |
| 59 | MP0001177_atelectasis | 0.99559183 |
| 60 | MP0005551_abnormal_eye_electrophysiolog | 0.98779976 |
| 61 | MP0004145_abnormal_muscle_electrophysio | 0.97886871 |
| 62 | MP0004043_abnormal_pH_regulation | 0.97852791 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 0.96346934 |
| 64 | MP0003075_altered_response_to | 0.95488983 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.95110686 |
| 66 | MP0004742_abnormal_vestibular_system | 0.94791427 |
| 67 | MP0000604_amyloidosis | 0.94345585 |
| 68 | MP0002229_neurodegeneration | 0.93683918 |
| 69 | MP0003121_genomic_imprinting | 0.90350177 |
| 70 | MP0005535_abnormal_body_temperature | 0.89421062 |
| 71 | MP0004085_abnormal_heartbeat | 0.88868078 |
| 72 | MP0000751_myopathy | 0.86619412 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.84905133 |
| 74 | MP0003632_abnormal_nervous_system | 0.84107930 |
| 75 | MP0003690_abnormal_glial_cell | 0.82347402 |
| 76 | MP0000920_abnormal_myelination | 0.82164704 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.79937617 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.79807241 |
| 79 | MP0002090_abnormal_vision | 0.78536130 |
| 80 | MP0003634_abnormal_glial_cell | 0.77632991 |
| 81 | MP0006072_abnormal_retinal_apoptosis | 0.76877064 |
| 82 | MP0005394_taste/olfaction_phenotype | 0.76783554 |
| 83 | MP0005499_abnormal_olfactory_system | 0.76783554 |
| 84 | MP0003122_maternal_imprinting | 0.76494323 |
| 85 | MP0005253_abnormal_eye_physiology | 0.76461107 |
| 86 | MP0002102_abnormal_ear_morphology | 0.74775498 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.74080375 |
| 88 | MP0000026_abnormal_inner_ear | 0.72424228 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.71072478 |
| 90 | MP0005171_absent_coat_pigmentation | 0.70814777 |
| 91 | MP0004484_altered_response_of | 0.70537801 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.70269985 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.67321999 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.66612219 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 0.66026273 |
| 96 | MP0003283_abnormal_digestive_organ | 0.64879216 |
| 97 | MP0004510_myositis | 0.64115046 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.62840377 |
| 99 | MP0001664_abnormal_digestion | 0.60717206 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60711648 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.59620741 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.55706991 |
| 103 | MP0002653_abnormal_ependyma_morphology | 0.55375616 |
| 104 | MP0010770_preweaning_lethality | 0.54917690 |
| 105 | MP0002082_postnatal_lethality | 0.54917690 |
| 106 | MP0010768_mortality/aging | 0.53903648 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.53685168 |
| 108 | MP0003878_abnormal_ear_physiology | 0.53685168 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.52580082 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.52351911 |
| 111 | MP0002234_abnormal_pharynx_morphology | 0.51321557 |
| 112 | MP0005187_abnormal_penis_morphology | 0.50442263 |
| 113 | MP0004233_abnormal_muscle_weight | 0.50241257 |
| 114 | MP0001943_abnormal_respiration | 0.49769959 |
| 115 | MP0005623_abnormal_meninges_morphology | 0.49708091 |
| 116 | MP0000566_synostosis | 0.49225240 |
| 117 | MP0003956_abnormal_body_size | 0.49200813 |
| 118 | MP0010769_abnormal_survival | 0.49084327 |
| 119 | MP0002638_abnormal_pupillary_reflex | 0.48636724 |
| 120 | MP0003861_abnormal_nervous_system | 0.48138179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.65869418 |
| 2 | Myokymia (HP:0002411) | 7.17460980 |
| 3 | Focal seizures (HP:0007359) | 6.17736674 |
| 4 | Visual hallucinations (HP:0002367) | 5.35836772 |
| 5 | Atonic seizures (HP:0010819) | 4.87644314 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.84167836 |
| 7 | Febrile seizures (HP:0002373) | 4.58613030 |
| 8 | Absence seizures (HP:0002121) | 4.52074540 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.16214253 |
| 10 | Dialeptic seizures (HP:0011146) | 4.15767424 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.07318351 |
| 12 | Action tremor (HP:0002345) | 3.91627092 |
| 13 | Broad-based gait (HP:0002136) | 3.87337296 |
| 14 | Poor eye contact (HP:0000817) | 3.64923711 |
| 15 | Hyperventilation (HP:0002883) | 3.51987931 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.49950022 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.42632612 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.42412359 |
| 19 | Impaired social interactions (HP:0000735) | 3.36861393 |
| 20 | Abnormal social behavior (HP:0012433) | 3.36861393 |
| 21 | Anxiety (HP:0000739) | 3.32110187 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.30780052 |
| 23 | Depression (HP:0000716) | 3.28390889 |
| 24 | Dysmetria (HP:0001310) | 3.24165830 |
| 25 | Truncal ataxia (HP:0002078) | 3.15487958 |
| 26 | Amblyopia (HP:0000646) | 3.15191829 |
| 27 | Ankle clonus (HP:0011448) | 3.11114291 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 3.02794727 |
| 29 | Neurofibrillary tangles (HP:0002185) | 2.96868676 |
| 30 | Mutism (HP:0002300) | 2.95323432 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.93937029 |
| 32 | Papilledema (HP:0001085) | 2.88233488 |
| 33 | Postural instability (HP:0002172) | 2.86122097 |
| 34 | Progressive inability to walk (HP:0002505) | 2.84330519 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.83292870 |
| 36 | Torticollis (HP:0000473) | 2.82621713 |
| 37 | Excessive salivation (HP:0003781) | 2.81863410 |
| 38 | Drooling (HP:0002307) | 2.81863410 |
| 39 | Scanning speech (HP:0002168) | 2.80096816 |
| 40 | Impaired smooth pursuit (HP:0007772) | 2.76449065 |
| 41 | Stereotypic behavior (HP:0000733) | 2.72744477 |
| 42 | Hemiparesis (HP:0001269) | 2.72551953 |
| 43 | Intention tremor (HP:0002080) | 2.71408980 |
| 44 | Urinary urgency (HP:0000012) | 2.62662592 |
| 45 | Focal dystonia (HP:0004373) | 2.62098592 |
| 46 | Diplopia (HP:0000651) | 2.61108108 |
| 47 | Abnormality of binocular vision (HP:0011514) | 2.61108108 |
| 48 | Genetic anticipation (HP:0003743) | 2.58088598 |
| 49 | Annular pancreas (HP:0001734) | 2.56598940 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 2.48495983 |
| 51 | Spastic gait (HP:0002064) | 2.48042471 |
| 52 | Status epilepticus (HP:0002133) | 2.46300370 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.45725396 |
| 54 | Bradykinesia (HP:0002067) | 2.43085800 |
| 55 | Absent speech (HP:0001344) | 2.42779685 |
| 56 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.42374252 |
| 57 | Gait imbalance (HP:0002141) | 2.38345109 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.37556345 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.37556345 |
| 60 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.36874834 |
| 61 | Craniofacial dystonia (HP:0012179) | 2.35321257 |
| 62 | Dysmetric saccades (HP:0000641) | 2.35297187 |
| 63 | Termporal pattern (HP:0011008) | 2.35255060 |
| 64 | Insidious onset (HP:0003587) | 2.35255060 |
| 65 | Postural tremor (HP:0002174) | 2.31183191 |
| 66 | Megalencephaly (HP:0001355) | 2.29898789 |
| 67 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29857455 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.26287720 |
| 69 | Hemiplegia (HP:0002301) | 2.25204842 |
| 70 | Fetal akinesia sequence (HP:0001989) | 2.23446944 |
| 71 | Inability to walk (HP:0002540) | 2.22457427 |
| 72 | Limb dystonia (HP:0002451) | 2.21600458 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.21531717 |
| 74 | Generalized myoclonic seizures (HP:0002123) | 2.19384103 |
| 75 | Ankyloglossia (HP:0010296) | 2.18265717 |
| 76 | Impaired vibratory sensation (HP:0002495) | 2.17184557 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.14642904 |
| 78 | Resting tremor (HP:0002322) | 2.11026609 |
| 79 | Akinesia (HP:0002304) | 2.09097860 |
| 80 | Amyotrophic lateral sclerosis (HP:0007354) | 2.04480474 |
| 81 | Pointed chin (HP:0000307) | 2.03821187 |
| 82 | Lower limb muscle weakness (HP:0007340) | 2.03062841 |
| 83 | Incomplete penetrance (HP:0003829) | 2.01858105 |
| 84 | Lower limb amyotrophy (HP:0007210) | 2.01619555 |
| 85 | Spastic tetraplegia (HP:0002510) | 1.99088418 |
| 86 | Lower limb asymmetry (HP:0100559) | 1.98424926 |
| 87 | Gait ataxia (HP:0002066) | 1.97850917 |
| 88 | Delusions (HP:0000746) | 1.96753663 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 1.95043824 |
| 90 | Spastic tetraparesis (HP:0001285) | 1.91672197 |
| 91 | Horizontal nystagmus (HP:0000666) | 1.91059703 |
| 92 | Obstructive sleep apnea (HP:0002870) | 1.89803530 |
| 93 | Esotropia (HP:0000565) | 1.89794720 |
| 94 | Cutaneous finger syndactyly (HP:0010554) | 1.89167587 |
| 95 | Abnormality of salivation (HP:0100755) | 1.88546788 |
| 96 | Inappropriate behavior (HP:0000719) | 1.87902709 |
| 97 | Psychosis (HP:0000709) | 1.87872381 |
| 98 | Blue irides (HP:0000635) | 1.86573223 |
| 99 | Abnormal EKG (HP:0003115) | 1.86298602 |
| 100 | Morphological abnormality of the middle ear (HP:0008609) | 1.81857738 |
| 101 | Polyphagia (HP:0002591) | 1.81819560 |
| 102 | Rapidly progressive (HP:0003678) | 1.81675677 |
| 103 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.81414728 |
| 104 | Aplasia of the phalanges of the hand (HP:0009802) | 1.81414728 |
| 105 | Aplasia involving bones of the extremities (HP:0009825) | 1.81414728 |
| 106 | Protruding tongue (HP:0010808) | 1.80661635 |
| 107 | Sleep apnea (HP:0010535) | 1.80654044 |
| 108 | Split foot (HP:0001839) | 1.80631045 |
| 109 | Rigidity (HP:0002063) | 1.79676824 |
| 110 | Neuroendocrine neoplasm (HP:0100634) | 1.79605851 |
| 111 | Medial flaring of the eyebrow (HP:0010747) | 1.77742835 |
| 112 | Abnormality of saccadic eye movements (HP:0000570) | 1.76495229 |
| 113 | Pheochromocytoma (HP:0002666) | 1.76382832 |
| 114 | Thickened helices (HP:0000391) | 1.75981714 |
| 115 | Clonus (HP:0002169) | 1.74336623 |
| 116 | Optic nerve hypoplasia (HP:0000609) | 1.70692195 |
| 117 | Cerebral hypomyelination (HP:0006808) | 1.70647448 |
| 118 | Congenital primary aphakia (HP:0007707) | 1.69241144 |
| 119 | Specific learning disability (HP:0001328) | 1.69151879 |
| 120 | Agitation (HP:0000713) | 1.67851165 |
| 121 | Retinal dysplasia (HP:0007973) | 1.66724655 |
| 122 | Type II lissencephaly (HP:0007260) | 1.66638943 |
| 123 | True hermaphroditism (HP:0010459) | 1.66634275 |
| 124 | Prolonged QT interval (HP:0001657) | 1.66463879 |
| 125 | Pancreatic fibrosis (HP:0100732) | 1.66173944 |
| 126 | Paraplegia (HP:0010550) | 1.66144190 |
| 127 | Lissencephaly (HP:0001339) | 1.65742472 |
| 128 | Apathy (HP:0000741) | 1.65340492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.83677791 |
| 2 | NTRK3 | 4.68052004 |
| 3 | MAP3K9 | 3.72746125 |
| 4 | RIPK4 | 2.81969138 |
| 5 | MAP3K4 | 2.80111124 |
| 6 | MARK1 | 2.57262554 |
| 7 | MINK1 | 2.55234943 |
| 8 | DAPK2 | 2.38555160 |
| 9 | MAP2K7 | 2.34088088 |
| 10 | KSR2 | 2.32987209 |
| 11 | PAK6 | 1.97131321 |
| 12 | PRKD3 | 1.89790055 |
| 13 | NTRK2 | 1.89412073 |
| 14 | CAMKK1 | 1.88399807 |
| 15 | MAP3K12 | 1.80020135 |
| 16 | MAP2K4 | 1.79949474 |
| 17 | NTRK1 | 1.76500197 |
| 18 | KSR1 | 1.76207707 |
| 19 | PNCK | 1.65371869 |
| 20 | ARAF | 1.63834698 |
| 21 | TNIK | 1.62905839 |
| 22 | DAPK1 | 1.59879683 |
| 23 | CDK5 | 1.55694989 |
| 24 | SIK2 | 1.53734761 |
| 25 | MAP3K13 | 1.50920807 |
| 26 | FES | 1.49570453 |
| 27 | BCR | 1.43696790 |
| 28 | CASK | 1.42975134 |
| 29 | PLK2 | 1.41453826 |
| 30 | FRK | 1.36735552 |
| 31 | GRK5 | 1.33387087 |
| 32 | CAMKK2 | 1.32216350 |
| 33 | MAP3K2 | 1.31147737 |
| 34 | BMPR2 | 1.29400092 |
| 35 | STK38 | 1.25335380 |
| 36 | PRKCG | 1.20786248 |
| 37 | TYRO3 | 1.19011992 |
| 38 | PRPF4B | 1.18723376 |
| 39 | WNK3 | 1.18113419 |
| 40 | WNK4 | 1.13920992 |
| 41 | CDK19 | 1.13889029 |
| 42 | MAP4K2 | 1.10130695 |
| 43 | MAPK13 | 1.08169200 |
| 44 | RAF1 | 1.07902712 |
| 45 | ADRBK2 | 1.07478551 |
| 46 | CAMK2A | 1.06558518 |
| 47 | CAMK2B | 0.99868367 |
| 48 | UHMK1 | 0.97663250 |
| 49 | PTK2B | 0.92826512 |
| 50 | DYRK2 | 0.88996451 |
| 51 | TAOK1 | 0.88634625 |
| 52 | CDK18 | 0.87199715 |
| 53 | STK39 | 0.86730110 |
| 54 | STK11 | 0.86484006 |
| 55 | CDK15 | 0.85918245 |
| 56 | CAMK1 | 0.85215174 |
| 57 | CDK14 | 0.84941466 |
| 58 | CSNK1A1L | 0.83255431 |
| 59 | PKN1 | 0.82255614 |
| 60 | PINK1 | 0.81358532 |
| 61 | SGK494 | 0.80995823 |
| 62 | SGK223 | 0.80995823 |
| 63 | CSNK1G3 | 0.77772082 |
| 64 | SGK1 | 0.76098523 |
| 65 | PRKCH | 0.75671695 |
| 66 | CDK11A | 0.75201100 |
| 67 | RET | 0.70688577 |
| 68 | LIMK1 | 0.69731940 |
| 69 | DYRK1A | 0.68610935 |
| 70 | OXSR1 | 0.67507255 |
| 71 | MARK2 | 0.67447009 |
| 72 | SGK2 | 0.66561864 |
| 73 | PAK3 | 0.65585221 |
| 74 | CSNK1G1 | 0.65249933 |
| 75 | PHKG1 | 0.64684022 |
| 76 | PHKG2 | 0.64684022 |
| 77 | LATS2 | 0.62557144 |
| 78 | PDK1 | 0.62085071 |
| 79 | PDPK1 | 0.60817437 |
| 80 | FGR | 0.60804256 |
| 81 | MAP3K1 | 0.59538691 |
| 82 | CAMK2D | 0.56148771 |
| 83 | SGK3 | 0.55625513 |
| 84 | CSNK1G2 | 0.55348717 |
| 85 | NME1 | 0.55207231 |
| 86 | BMPR1B | 0.54524407 |
| 87 | PRKCZ | 0.53870367 |
| 88 | PRKCE | 0.53447968 |
| 89 | TNK2 | 0.52898890 |
| 90 | ALK | 0.51964286 |
| 91 | PRKG1 | 0.50501903 |
| 92 | CSNK1D | 0.49308851 |
| 93 | FYN | 0.48509813 |
| 94 | CAMK2G | 0.48312667 |
| 95 | MAP2K1 | 0.47875217 |
| 96 | RPS6KA3 | 0.47356563 |
| 97 | NEK6 | 0.46986055 |
| 98 | MAPK10 | 0.44777156 |
| 99 | WNK1 | 0.44711227 |
| 100 | MAP3K6 | 0.44182999 |
| 101 | MAPK12 | 0.43209220 |
| 102 | CSNK1A1 | 0.41971677 |
| 103 | CAMK1G | 0.40983516 |
| 104 | FER | 0.40833886 |
| 105 | MAP3K7 | 0.37648869 |
| 106 | ROCK2 | 0.37175851 |
| 107 | ADRBK1 | 0.36930413 |
| 108 | LMTK2 | 0.36751185 |
| 109 | DMPK | 0.36731567 |
| 110 | FGFR2 | 0.36338799 |
| 111 | DAPK3 | 0.36134024 |
| 112 | MUSK | 0.35546259 |
| 113 | BRAF | 0.35070372 |
| 114 | GRK1 | 0.34787034 |
| 115 | RPS6KB1 | 0.33751661 |
| 116 | PRKCB | 0.33030908 |
| 117 | CAMK4 | 0.32614259 |
| 118 | CDK3 | 0.31636783 |
| 119 | ERBB3 | 0.31571338 |
| 120 | MOS | 0.31413580 |
| 121 | TRIM28 | 0.31333276 |
| 122 | TAOK3 | 0.31140249 |
| 123 | RIPK1 | 0.30885038 |
| 124 | ERBB2 | 0.30235425 |
| 125 | ROCK1 | 0.30222693 |
| 126 | PRKACA | 0.29959095 |
| 127 | PRKCA | 0.29357425 |
| 128 | CDC42BPA | 0.29183543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.83866565 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.98196230 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.91377529 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.87045747 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78120335 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.77301696 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76505917 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.70586689 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.67104264 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.63482728 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.29096767 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.27878946 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14004483 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.95576846 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91298586 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.89756116 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.87784281 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84165909 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.83701471 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.82788198 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.82691593 |
| 22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.78150696 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.74560724 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.70297663 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65967607 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46898792 |
| 27 | Gap junction_Homo sapiens_hsa04540 | 1.40421934 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36280281 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36042216 |
| 30 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32765289 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29684505 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21586568 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.16439586 |
| 34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12997638 |
| 35 | Phototransduction_Homo sapiens_hsa04744 | 1.11448773 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.10068939 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.08507927 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07758338 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06222584 |
| 40 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05680507 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.05528442 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04161370 |
| 43 | Melanogenesis_Homo sapiens_hsa04916 | 1.02669778 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98893674 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95878230 |
| 46 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92539535 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92282248 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91836578 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87199792 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85531031 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83139088 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81631644 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80908586 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77591308 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77279520 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.77215000 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76502385 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75519493 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71145546 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69306422 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67319234 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63110020 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62311605 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61195099 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58456417 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58438713 |
| 67 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58231623 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57870702 |
| 69 | Alcoholism_Homo sapiens_hsa05034 | 0.57307540 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56611466 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56330623 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55113712 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54596416 |
| 74 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54285505 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54224492 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53898401 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53788626 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53095120 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52628827 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48685898 |
| 81 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48672957 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47911744 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47096899 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46793857 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46236425 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45338918 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.44855771 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.42988995 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41637647 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.40745367 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40518962 |
| 92 | Prion diseases_Homo sapiens_hsa05020 | 0.39968480 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38887977 |
| 94 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37685654 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37035985 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36241503 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35877045 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35077232 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34271873 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33393690 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33311566 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.32447444 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.30216362 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29357500 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28708509 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28322071 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.28151648 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.28025266 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.27741537 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27691999 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27556046 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25999159 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.25662130 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24428921 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22914008 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.22721098 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22587519 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.19661434 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.18208380 |
| 120 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18178970 |

